National Cancer Institute
Rockville, MD
Agency facts
- Acronym
-
- NCI
- Office code
- 75N910
- Organization
-
-
Parent
NIH
- NCI
-
Parent
NIH
- Contract obligations
- $1,027,826,253 In FY2025
Agency codes and contract spending come from SAM.gov/FPDS.
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $7,646,466 |
| FY2026 | $1,128,325,817 |
| FY2025 | $1,027,826,253 |
| FY2024 | $1,348,031,309 |
| FY2023 | $1,287,010,872 |
Top contractors by obligations
| Rank | Contractor | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Leidos Biomedical Research Inc. | $617,525,400 | |
| 2 | Westat, Inc. | $32,343,080 | |
| 3 | Information Management Services, Inc. | $32,091,533 | |
| 4 | Essex Management LLC | $26,688,258 | |
| 5 | Deloitte & Touche LLP | $26,201,501 | |
| 6 | Technical Resources International, Inc. | $18,461,737 | |
| 7 | Ctis, Inc. | $18,200,000 | |
| 8 | The Emmes Company, LLC | $17,866,093 | |
| 9 | Fred Hutchinson Cancer Center | $13,898,769 | |
| 10 | ICF Incorporated, L.L.C. | $12,771,701 |
Top contract vehicles by obligations
| Rank | Vehicle | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Multiple Award Schedule (MAS) | $130,772,071 | |
| 2 | NCI Critical and Complex IT Services | $65,692,718 | |
| 3 | Surveillance Epidemiology and End Results (SEER) | $40,237,386 | |
| 4 | Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) | $38,769,453 | |
| 5 | Biomedical Information Technology, Software Development, and Informatics Support (BITSDIS) | $29,938,326 | |
| 6 | Cancer Trials Support Unit | $24,194,616 | |
| 7 | Chief Information Officer Commodities and Solutions (CIO-CS) | $11,526,628 | |
| 8 | Cancer Study Cohort Recruitment | $11,314,136 | |
| 9 | Solutions for Enterprise Wide Procurement V (SEWP V) | $10,897,532 | |
| 10 | Scientific, Operations, and Administrative Resources to the National Institutes of Health (SOAR) | $9,484,307 |
10 of 35 vehicles listed here. See the rest on GovTribe.
Contract opportunities
Show 40 more
Latest 50 of 1,266 listed here. See the rest on GovTribe.
Contracting staff
| Rank | Person | SAM.gov records, last 2 years |
|---|---|---|
| 1 | David Romley | 7 |
About this agency
The National Institutes of Health National Cancer Institute, a sub-agency within the cabinet-level Department of Health and Human Services, administers federal contracts and grants supporting cancer research, prevention, and treatment through intramural and extramural funding mechanisms. NCI is the principal federal funding and coordinating body for the National Cancer Program and manages its portfolio across multiple institutes and centers within NIH.
NCI's contract portfolio totals 25,580 federal contract awards since 1992, with a combined potential value of $204.12 billion and $24.34 billion obligated. Recent activity has declined: 1,170 awards in 2023, 1,071 in 2024, 362 in 2025, 409 in 2026, and 1 year-to-date in 2027. The agency transacts with 3,411 distinct prime contractors, and competitive concentration among recent primes is fragmented; the top five primes by award count hold 19 percent of recent awards. Olgoonik Federal LLC leads by count with 233 awards ($5.1 million combined potential value), followed by Weems Design Studio Inc. with 204 awards ($49.1 million), and Illumina Inc. with 173 awards ($20.6 million). By potential value, Leidos Biomedical Research Inc. dominates with $1.64 billion combined potential value across 75 awards (2026–2027 estimated), dwarfing the top five by value, which collectively represent only 1 percent of recent combined potential value. The agency's contract base transacts heavily through Schedule task orders, BPA calls, modifications, and below-threshold purchase orders; reported potential value does not capture the full value flow. The set-aside mix is heavily skewed toward unrestricted procurement: 90 percent of awards carry no set-aside designation, 7 percent are small-business set-asides, and 2 percent are 8(a) sole source. Remaining designations—woman-owned small business, service-disabled veteran-owned small business, HUBZone, and economically disadvantaged woman-owned small business—each account for less than 1 percent.
NCI's grant portfolio totals 22,746 federal grant awards since 1975, with $80.95 billion in federal dollars obligated. Recent cadence: 1,763 awards in 2023, 1,734 in 2024, 1,215 in 2025, 1,404 in 2026, and 70 so far in 2027. The agency maintains 1,594 distinct grant recipients. Grant recipient concentration among recent awardees is fragmented; the top five recipients hold 12 percent of recent awards and 3 percent of recent federal dollars obligated. The University of Texas M.D. Anderson Cancer Center leads with 256 awards and $622.3 million federal dollars obligated, followed by Sloan-Kettering Institute for Cancer Research with 209 awards and $545.6 million, and University of Pennsylvania Trustees with 173 awards and $447.6 million. The grant assistance-type mix is predominantly Project Grants (83 percent) with a smaller allocation to Cooperative Agreements (17 percent).
Recent contract opportunities reflect NCI's core research and facility-support needs. An Indefinite Delivery/Indefinite Quantity subcontract for construction services at the Frederick National Laboratory for Cancer Research (operated by Leidos Biomedical Research) closed 20 November 2026. A small-business sources-sought notice for cervical cancer screening follow-up closed 26 October 2026. Notice of Intent postings include sole-source awards for Psomagen Inc.'s GEM-X cell quality control and sequencing (closed 21 September 2026) and Vision RT Inc.'s maintenance service for specialized radiotherapy tracking systems (closed 26 August 2026). A solicitation for prediction-error development in competing-risks survival models was awarded to Jason Fine on a sole-source basis (closed 9 September 2026), and a solicitation for production of ChAdOx-1 and MVA viral vectors expressing mouse gp70 was posted 17 August 2026 with an intended award to the Viral Vector Core at University of Oxford's Pandemic Institute.
Description
NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
Quick answers
What is National Cancer Institute?
National Cancer Institute (NCI) is part of National Institutes of Health, Department of Health and Human Services.
How much does National Cancer Institute spend on contracts?
Contracts funded by National Cancer Institute and its offices obligated $1,027,826,253 in fiscal year 2025 and $4,798,840,717 in fiscal years 2023 through 2027.
Who are National Cancer Institute's largest contractors?
The contractors National Cancer Institute and its offices obligated the most to in fiscal years 2026 and 2027 are Leidos Biomedical Research Inc. ($617,525,400), Westat, Inc. ($32,343,080) and Information Management Services, Inc. ($32,091,533).
Which contract vehicles does National Cancer Institute use most?
The contract vehicles National Cancer Institute and its offices obligated the most through in fiscal years 2026 and 2027 are Multiple Award Schedule (MAS) ($130,772,071), NCI Critical and Complex IT Services ($65,692,718) and Surveillance Epidemiology and End Results (SEER) ($40,237,386). Orders through any contract vehicle obligated $328,397,750 in those years, 29% of its contract obligations.
What is National Cancer Institute's latest contract opportunity?
The latest contract opportunity from National Cancer Institute is NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research”, special notice, posted October 20, 2026.
On GovTribe
See the full record
- Federal contract opportunities
- Federal contract awards it made
- Federal contract awards it funded
- IDV awards it made
- IDV awards it funded
- Contract vehicles it funds
- Federal grant awards
- Funding analysis by contractor, NAICS and set-aside
- Contacts at this agency
- Ask GovTribe AI about this agency